🇺🇸 FDA
Pipeline program

HEC 68498

PCD-DHEC68498-17-001

Phase 1 small_molecule completed

Quick answer

HEC 68498 for Idiopathic Pulmonary Fibrosis is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Idiopathic Pulmonary Fibrosis
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials